Brainstorm Cell Therapeut... (BCLI)
NASDAQ: BCLI
· Real-Time Price · USD
0.69
-0.01 (-1.43%)
At close: Sep 26, 2025, 1:23 PM
Brainstorm Cell Therapeutics Revenue
Brainstorm Cell Therapeutics reported an annual revenue of $849K, reflecting a 0% growth. For the quarter ending June 30, 2025, Brainstorm Cell Therapeutics generated $0 in revenue.
Revenue (ttm)
849K
Revenue Growth
n/a
Price / Sales Ratio
14.2
Revenue / Employee
31.44K
Employees
27
Market Cap
7.16M
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 849K | +Infinity% |
| Dec 31, 2023 | 0 | n/a |
| Dec 31, 2022 | 0 | n/a |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | +-100.00% |
| Dec 31, 2019 | -366K | -Infinity% |
| Dec 31, 2018 | 0 | n/a |
| Dec 31, 2017 | 0 | n/a |
| Dec 31, 2016 | 0 | n/a |
| Dec 31, 2015 | 0 | n/a |
| Dec 31, 2014 | 0 | n/a |
| Dec 31, 2013 | 0 | n/a |
| Dec 31, 2012 | 0 | n/a |
| Dec 31, 2011 | 0 | n/a |
| Dec 31, 2010 | 0 | n/a |
| Dec 31, 2009 | 0 | n/a |
| Dec 31, 2008 | 0 | n/a |
| Dec 31, 2007 | 0 | n/a |
| Dec 31, 2006 | 0 | n/a |
| Mar 31, 2005 | 0 | n/a |
| Mar 31, 2004 | 0 | -100.00% |
| Mar 31, 2003 | 82.89K | +261.96% |
| Mar 31, 2002 | 22.9K | n/a |